Neuropsychopharmacology

by W.W. Fleischhacker (Editor), D.J. Brooks (Editor)

Overview

The 5th Neuropsychiatry Symposium of the European Institute of Health- care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro- ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean- Charles Schwartz and colleagues set the stage with their paper on constitu- tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero- tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin- son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu- roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising.

Product Details

ISBN-13:	9783211839027
Publisher:	Springer Vienna
Publication date:	06/05/2003
Series:	Journal of Neural Transmission. Supplementa , #64
Edition description:	Softcover reprint of the original 1st ed. 2003
Pages:	117
Product dimensions:	8.50(w) x 11.02(h) x 0.01(d)

Table of Contents

Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor.- The role of peptides in treatment of psychiatric disorders.- Pharmacological approaches to migraine.- Advances in the pharmacological management of Parkinson disease.- Depression and antisocial personality disorder: two contrasting disorders of 5HT function.- Future directions in substance dependence research.- New developments in the pharmacotherapy of schizophrenia.

Editorial Reviews

Reviewer: Michael Schrift, DO (University of Washington School of Medicine)
Description: This a new book based on a meeting entitled The 5th Neuropsychiatry Symposium of the European Institute of Healthcare which apparently took place April 2003 (not clear from the book). As the title reveals, the book's focus is on neuropsychopharmacology. Written and edited by European researchers/clinicians, it is a valuable contribution to the field.
Purpose: The purpose of the book (and conference), according to the editors, is to bridge the gap between basic neuroscience and clinical psychiatry and neurology. The editors and authors have essentially provided journal style literature reviews on clinically relevant topics in the field.
Audience: The intended audience is clinicians and researchers in the fields of neurology and psychiatry.
Features: The book covers such topics as the therapeutic implications of receptors that have spontaneous agonist activity with the histamine H3 receptor as an example, neuropeptides in psychiatry; treatment of migraine, pharmacological management of Parkinson's Disease, serotonin in antisocial personality and depression, future neurobiological research in substance abuse, and new pharmacotherapy strategies for schizophrenia. Each chapter ends with relevant and timely references. An index section would have been useful.
Assessment: Although this new book which contains journal style literature reviews on various neuropsychiatric topics has some interesting chapters, the book is not worth the steep price!

Doody's Review Service